News
Medtronic's Jason Fontana offers an update on next-generation Symplicity Spyral devices, procedures and a new feature they're ...
5d
GlobalData on MSNGeneticure’s test obtains US patent to predict renal denervation responseThe patented method uses genetic markers and a weighted algorithm to assess the responsiveness to renal denervation.
About the Paradise Ultrasound Renal Denervation System The Paradise uRDN system is a first-of-its-kind ultrasound-based RDN ...
On Thursday, the US Centers for Medicare & Medicaid Services (CMS) issued its proposal for covering radiofrequency- or ...
Medtronic and Recor Medical both issued statements supporting new Medicare coverage for their respective renal denervation ...
5d
Stocktwits on MSNCMS’s Initial Proposal To Cover Renal Denervation A Win For Medtronic, Says AnalystsAnalysts are optimistic about Medtronic (MDT) after the Centers for Medicare and Medicaid Services (CMS) proposed to cover ...
To the surprise of no one in the device industry, the Medicare national coverage analysis for renal denervation (RDN) includes both radiofrequency and ultrasound technologies, but the agency has ...
David’s blood pressure was dangerously high until he received specialized care and renal denervation at BIDMC’s Complex Hypertension Clinic. Read his story.
CMS proposed Medicare coverage for Medtronic's renal denervation therapy for high blood pressure, signaling a key step toward ...
Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”), today announced their support for ...
The Centers for Medicare & Medicaid Services (CMS) issued a proposed decision memo for its National Coverage Analysis (NCA) ...
Atrioventricular interval modulation is being studied for patients with uncontrolled hypertension. Could the new technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results